Business
MIMEDX Announces Speakers for December 7 Investor Day
Company to Host Virtual Event on December 7, 2021 Beginning at 9:00 a.m. ET MARIETTA, Ga., Nov. 30, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG)
About this update from Mimedx Group, Inc
[{"type":"text","content":"Company to Host Virtual Event on December 7, 2021 Beginning at 9:00 a.m. ET MARIETTA, Ga., Nov. 30, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or “the Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the speakers for its upcoming virtual Investor Day that will be held on Tuesday, December 7, 2021 at 9:00 a.m. ET. Timothy R. Wright, MIMEDX Chief Executive Officer, commented, “Our team is excited to share additional analyses from the Company’s knee osteoarthritis (KOA) clinical study, following the third-party review and validation of both a statistically significant and clinically meaningful outcome in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total, WOMAC Pain and WOMAC Function scores for the Pre-Interim Analysis Cohort of 190 patients, with probability values less than 0.05 at three months and less than 0.01 at six months. We also look forward to discussing the strong growth potential for our commercial business as we capitalize on market development strategies, global expansion opportunities and product innovation initiatives to deliver double-digit growth in 2022 and beyond.” The MIMEDX Investor Day will feature Company leadership, third-party experts and key opinion leaders who will provide updates on the musculoskeletal late-stage pipeline and robust commercial business. Speakers and topics include: Company Updates Timothy R. Wright, Chief Executive Officer, MIMEDXPeter M. Carlson, EVP, Chief Financial Officer, MIMEDX Musculoskeletal Pipeline KOA Key Findings & Path Forward Robert B. Stein, M.D., Ph.D., EVP, Research and Development, MIMEDXMichelle Massee, AVP, Product Development, MIMEDXThomas M. Mick, M.D., Medical Director, Clinical Development, MIMEDXVibeke Strand, M.D., Stanford University School of MedicineKris J. Alden, M.D., Ph.D., Orthopaedic Surgeon, Hip, Knee & Shoulder Reconstruction Commercial Business Growth Strategy & Market Opportunity Rohit Kashyap, Ph.D., EVP, Chief Commercial Officer, MIMEDXJohn Harper, Ph.D., SVP R&D, Chief Technology Officer, MIMEDXWilliam H. Tettelbach, M.D., Principal Medical Officer, Head of Medical Affairs, MIMEDXBidhan B. Das, M.D., Colon, Rectal & General SurgeonCaroline Clarke, M.D., Plastic, Reconstructive & Cosmetic SurgeonJonathan Labovitz, D.P.M., Wes...